AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Byline: Carey Hamilton
Oct. 1--Like millions of Americans, Judith Krengel of Centerville was shocked to hear Thursday that Merck & Co. voluntarily pulled Vioxx from the market after clinical trials found increased risk of heart attack and stroke for long-term users.
She had been taking the arthritis and acute pain medication on and off for five years, to treat arthritis and fibromyalgia.
"My husband called me and said, 'Aren't you on that, sweetheart?'" said Krengel, 53, who works at the Davis County Health Department. "I took it this morning but am going to stop and call my doctor today. What makes me sad is this has helped so many people to decrease inflammation and stiffness."
Merck began selling the popular drug in 1999, with sales surging to more than $2.5 billion last year.
"We are…
Source: HighBeam Research, Utah patients seek options after maker recalls arthritis drug.